This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Effective treatment in rare but deadly form of cancer

Effective treatment in rare but deadly form of cancer
Credit: Paul Björkman, Sahlgrenska Universitetssjukhuset

An advanced surgical therapy has proved considerably more efficacious than conventional treatments for patients with melanoma in the eye (uveal) that has spread to the liver, a University of Gothenburg study shows. The treatment involves perfusing the liver with very high doses of chemotherapy.

Melanoma in the eye (uveal) is an unusual form of melanoma that arises not in the pigment cells of the skin but in the eye. In Sweden, some 80 people are diagnosed with the disease annually. In half of the patients, this form of cancer causes metastases, which entail a highly unfavorable prognosis. After metastases in the liver have been found, a large majority of patients die within one year. Unfortunately, with immunotherapy or chemotherapy have only very limited effects.

In the new study, 87 patients with metastasized were assigned to receive either the established treatment regarded by the patient's doctor as the best option or the current experimental therapy, known as "isolated hepatic perfusion" (IHP). The results of the trial are published in the Journal of Clinical Oncology.

Tumors shrank in 40% of patients

In the group undergoing IHP treatment, the subsequent X-ray examination showed that the tumors had shrunk in 39.5% of patients compared to only 4.5% of the patients in the group receiving conventional treatment.

"This is the first therapy that's been shown to shrink tumors as effectively for this group of patients. Our long-term goal is to enable the patients to become cancer-free, but to date, we haven't been able to say that the treatment can cure the patients," says Professor Roger Olofsson Bagge of the University of Gothenburg and senior consultant surgeon at Sahlgrenska University Hospital.

The study and treatment method have aroused keen interest worldwide. Discussions at an international level will potentially lead to the new treatment being recommended for this patient category.

Effective treatment in rare but deadly form of cancer
Credit: Paul Björkman, Sahlgrenska Universitetssjukhuset

Major operation

The IHP procedure is a large-scale involving open surgery in which the liver is surgically isolated and connected to a heart-lung machine. Extremely high doses of a chemotherapeutic agent are then pumped through the lever for one hour, after which all the chemotherapy is flushed away and the liver reconnected to the patient's own circulation. Using this method, it is possible to administer an extremely high dose of chemotherapy concentrated to the part of the body that harbors the , while the rest of the body does not get any adverse effects.

"It's a major operation involving , but next year we'll be starting to use a minimally invasive method where the liver is isolated with balloons inserted into the blood vessels of the groin," Olofsson Bagge says.

Since this form of cancer is so unusual, it has taken nearly ten years to complete the clinical phase III study. Almost all of Sweden's university hospitals have contributed patients to the study, but the actual IHP treatment has been implemented at Sahlgrenska University Hospital.

The treatment was developed in the U.S. back in the 1960s. It has been tested for a number of tumor diseases, but only now has a study succeeded in showing how efficacious the therapy is specifically for with uveal melanoma that has metastasized (spread) to the liver.

More information: Roger Olofsson Bagge et al, Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial), Journal of Clinical Oncology (2023). DOI: 10.1200/JCO.22.01705

Journal information: Journal of Clinical Oncology

Citation: Effective treatment in rare but deadly form of cancer (2023, March 21) retrieved 4 June 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Clinical trial: New combination treatment for eye melanoma increased patient survival


Feedback to editors